Exogenous H2S has also been observed to improve outcomes in non-alcoholic fatty liver disease by inhibiting the ER stress/NLRP3 inflammasome pathway [53]. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.